Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans

Diabetes

Volumn 59, Issue 4, 2010, Pages 1074-1081

  Hedrington, Maka S ^a   Farmerie, Stephnie ^a   Ertl, Andrew C ^a   Wang, Zhihui ^a   Tate, Donna B ^a   Davis, Stephen N ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b Veterans Affairs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADRENALIN; ALPRAZOLAM; GLUCAGON; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; NORADRENALIN; PANCREAS POLYPEPTIDE; PLACEBO; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; INSULIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; LIPOLYSIS; MALE; NERVE CONDUCTION; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; SYMPATHETIC TONE; TREATMENT RESPONSE; ADRENERGIC SYSTEM; BLOOD; CHEMICALLY INDUCED DISORDER; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADULT; ALPRAZOLAM; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; FEMALE; GABA MODULATORS; GLUCAGON; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; RECEPTORS, GABA-A; REFERENCE VALUES; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 77951148698     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-1520     Document Type: Article

References (32)

1. Cryer PE. Mechanisms of sympatho-adrenal failure and hypoglycemia in diabetes. J Clin Invest 2006;116:1470-1473
2. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-756
3. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
4. NICE-Sugar Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297
5. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002;51:724-733
6. Chan O, Cheng H, Herzog R, Czyzyk D, Zhu W, Wang A, McCrimmon RJ, Seashore MR, Sherwin RS. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 2008;57:1363-1370
7. A receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes 2006;55:1080-1087
8. Van Vugt DA, Washburn DL, Farley AE, Reid RL. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam. Neuroendocrinology 1997;65(5):344-352
9. Giordano R, Grottoli S, Brossa P, Pellegrino M, Destefanis S, Lanfranco F, Gianotti L, Ghigo E, Arvat E. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf) 2003;59:314-320
10. Breier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biol Psychiatry 1992;32:880-890
11. Smith D, Pernet A, Rosenthal JM, Bingham EM, Reid H, Macdonald IA, Amiel SA. The effect of modanifil on counter-regulatory and cognitive responses to hypoglycaemia. Diabetologia 2004;47:1704-1711
12. Abumrad NN, Rabin D, Diamond MC, Lacy WW. Use of a heated superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man. Metabolism 1981;30:936-940
13. DeFronzo RA, Tobin K, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E216-E223
14. Amiel SA, Tamborlane W, Simonson D, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987;31:1376-1383
15. Wall JS, Steele R, Debodo RD, Altszuler N. Effect of insulin on utilization and production of circulating glucose. Am J Physiol 1957;189:43-50
16. Wallin BG, Sundlof G, Eriksson BM, Dominiak P, Grobecker H, Lindblad LE. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 1981;111:69-73
17. Cherrington AD, Williams PE, Harris MS. Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism 1978;27:787-791
18. Aguilar-Parada E, Eisentraut AM, Unger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 1969;257:415-419
19. Wide L, Porath J. Radioimmunoassay of proteins with the use of sephadex-coupled antibodies. Biochim Biophys Acta 1966;130:257-260
20. Causon R, Caruthers M, Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrical detection. Anal Biochem 1981;116:223-226
21. Hunter W, Greenwood F. Preparation of [131I]-labeled human growth hormone of high specific activity. Nature 1962;194:495-496
22. Hagopian W, Lever E, Cen D, Emmounoud D, Polonsky K, Pugh W, Moosa A, Jaspan JB. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol 1983;245:171-177
23. Lloyd B, Burrin J, Smythe P, Alberti KGMM. Enzymatic fluorometric continuous-flow assays for blood glucose lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 1978;24:1724-1729
24. Ho RJ. Radiochemical assay of long chain fatty acid using 63NI as tracer. Anal Biochem 1970;26:105-113
25. Dreary L, Hepburn D, Macleod K, Frier BM. Partitioning the symptoms of hypoglycemia using multi-sample confirmatory factor analysis. Diabetologia 1993;36:761-770
26. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004;350:2272-2279
27. McCann SM, Rettori V. Gamma amino bytyric acid (GABA) controls anterior pituitary hormone secretion. Adv Biochem Psychopharmacol 1986;42:173-189
28. Lang CH. Inhibition of central GABAA receptors enhances hepatic glucose production and peripheral glucose uptake. Brain Res Bull 1995;37:611-616
29. Beverly JL, DeVries M, Bouman S, Arseneau L. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia. Am J Physiol Reg Int Comp Physiol 2001;280:R563-R569
30. Castro E, Oset-Gasque M, Gonzalez M. GABAA and GABAB receptors are functionally active in the regulation of catecholamine secretion by bovine chromaffin cells. J Neurosci Res 1989;23:290-296
31. Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagons response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. Diabetes 2005;54:757-764
32. Havel PJ, Ahren B. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 1997;46:801-807